Australia markets open in 7 hours 9 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4000+0.0300 (+2.19%)
As of 11:45AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.62-0.56-2.41-0.72
Low estimate-0.62-0.56-2.41-0.72
High estimate-0.62-0.56-2.41-0.72
Year ago EPS-0.6-0.53-2.62-2.41
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate1.26M1.42M4.63M10.28M
Low estimate1.26M1.42M4.63M10.28M
High estimate1.26M1.42M4.63M10.28M
Year ago sales570k796k2.51M4.63M
Sales growth (year/est)121.10%78.40%84.60%122.00%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS-0.66-0.53-0.58-0.73
Actual EPS-0.6-0.53-0.67-0.56
Difference0.060-0.090.17
Surprise %9.10%0.00%-15.50%23.30%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.62-0.56-2.41-0.72
7 days ago-0.62-0.56-2.41-0.72
30 days ago-0.62-0.56-2.41-0.72
60 days ago-0.53-0.5-2.44-1.32
90 days ago-0.53-0.5-2.44-1.32
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.-3.30%N/AN/AN/A
Next qtr.-5.70%N/AN/AN/A
Current year8.00%N/AN/AN/A
Next year70.10%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A